Literature DB >> 19100795

Nucleic acid delivery with chitosan and its derivatives.

Wing-Fu Lai1, Marie Chia-Mi Lin.   

Abstract

Chitosan is a naturally occurring cationic mucopolysaccharide. It is generally biocompatible, biodegradable, mucoadhesive, non-immunogenic and non-toxic. Although chitosan is able to condense nucleic acids (NA) (both DNA and RNA) and protect them from nuclease degradation, its poor water solubility and low transfection efficacy have impeded its use as an NA carrier. In order to overcome such limitations, a multitude of strategies for chitosan modification and formulation have been proposed. In this article, we will first give a brief overview of the physical and biological properties of chitosan. Then, with a special focus on plasmid DNA delivery, we will have a detailed discussion of the latest advances in chitosan-mediated NA transfer. For future research, the following three important areas will be discussed: chitosan-mediated therapeutic small RNA transfer, structure-activity relationships (SAR) in chitosan vector design, and chitosan-mediated oral/nasal NA therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100795     DOI: 10.1016/j.jconrel.2008.11.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  37 in total

1.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

2.  Molecular and engineering approaches to regenerate and repair teeth in mammals.

Authors:  Wing-Fu Lai; Jong-Min Lee; Han-Sung Jung
Journal:  Cell Mol Life Sci       Date:  2013-11-24       Impact factor: 9.261

3.  Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.

Authors:  Jianghong Xu; Wenjia Dai; Zhengmin Wang; Bing Chen; Zhongming Li; Xiaoyong Fan
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

Review 4.  Nucleic acid therapy for lifespan prolongation: present and future.

Authors:  Wing-Fu Lai
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

5.  Treating cutaneous aging with patented technologies.

Authors:  Wing-Fu Lai; Marie C Lin
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

Review 6.  Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.

Authors:  Tatiana N Demidova-Rice; Michael R Hamblin; Ira M Herman
Journal:  Adv Skin Wound Care       Date:  2012-08       Impact factor: 2.347

Review 7.  MicroRNAs as regulators of cutaneous wound healing.

Authors:  Wing-Fu Lai; Parco M Siu
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

8.  Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.

Authors:  Ana Vanessa Nascimento; Florence Gattacceca; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Nanomedicine (Lond)       Date:  2016-03-16       Impact factor: 5.307

9.  ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin.

Authors:  Sreekanth Reddy Obireddy; Wing-Fu Lai
Journal:  Int J Nanomedicine       Date:  2022-02-08

Review 10.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.